相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Intravenous Siponimod: A Randomized, Open-label Study in Healthy Subjects
Kasra Shakeri-Nejad et al.
CLINICAL THERAPEUTICS (2020)
FTY720 Regulates Mitochondria Biogenesis in Dendritic Cells to Prevent Kidney Ischemic Reperfusion Injury
Thomas Rousselle et al.
FRONTIERS IN IMMUNOLOGY (2020)
Role and plasticity of Th1 and Th17 responses in immunity to Staphylococcus aureus
Alessandra Ferraro et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Circulating Th1, Th2, Th17, Treg, and PD-1 Levels in Patients with Brucellosis
Rongjiong Zheng et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells
Ahmet Eken et al.
FRONTIERS IN IMMUNOLOGY (2019)
Sphingosine-1-phosphate receptors and innate immunity
Arielle M. Bryan et al.
CELLULAR MICROBIOLOGY (2018)
Dectin-1-Syk-CARD9 Signaling Pathway in TB immunity
Matthew Wagener et al.
FRONTIERS IN IMMUNOLOGY (2018)
S1P receptor antagonists fingolimod and siponimod do not improve the outcome of experimental autoimmune myasthenia gravis mice after disease onset
Andreas Pelz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation
Katja Thomas et al.
JOURNAL OF NEUROINFLAMMATION (2017)
S1P1 deletion differentially affects TH17 and Regulatory T cells
Ahmet Eken et al.
SCIENTIFIC REPORTS (2017)
IL-23R-activated STAT3/STAT4 is essential for Th1/Th17-mediated CNS autoimmunity
Priscilla W. Lee et al.
JCI INSIGHT (2017)
Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery
Soo-Jin Park et al.
BIOMOLECULES & THERAPEUTICS (2017)
Curdlan activates dendritic cells through dectin-1 and toll-like receptor 4 signaling
Hyung Sook Kim et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Fingolimod does not impair T-cell release from the thymus and beneficially affects Treg function in patients with multiple sclerosis
Juergen Haas et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Fingolimod does not impair T-cell release from the thymus and beneficially affects Treg function in patients with multiple sclerosis
Juergen Haas et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Sphingosine-1-phosphate differently regulates the cytokine production of IL-12, IL-23 and IL-27 in activated murine bone marrow derived dendritic cells
Katrin Schaper et al.
MOLECULAR IMMUNOLOGY (2014)
Role of sphingosine 1-phosphate (S1P) and effects of fingolimod, an S1P receptor 1 functional antagonist in lymphocyte circulation and autoimmune diseases
Kenji Chiba et al.
AIMS MOLECULAR SCIENCE (2014)
Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer
Jie Liang et al.
CANCER CELL (2013)
Identification of Canonical Tyrosine-dependent and Non-canonical Tyrosine-independent STAT3 Activation Sites in the Intracellular Domain of the Interleukin 23 Receptor
Doreen M. Floss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Circulating Monocytes Are Reduced by Sphingosine-1-Phosphate Receptor Modulators Independently of S1P3
Nuruddeen D. Lewis et al.
JOURNAL OF IMMUNOLOGY (2013)
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination
Abdolmohamad Rostami et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation
Christopher S. Garris et al.
NATURE IMMUNOLOGY (2013)
Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator
Shifeng Pan et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Clinical Pharmacokinetics of Fingolimod
Olivier J. David et al.
CLINICAL PHARMACOKINETICS (2012)
Life, death, and miracles: Th17 cells in the intestine
Samuel Huber et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Induction and molecular signature of pathogenic TH17 cells
Youjin Lee et al.
NATURE IMMUNOLOGY (2012)
Inducible NO synthase and antibacterial host defence in times of Th17/Th22/T22 immunity
Heiko Muehl et al.
CELLULAR MICROBIOLOGY (2011)
The many faces of Th17 cells
Anneli Peters et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF
Mohamed El-Behi et al.
NATURE IMMUNOLOGY (2011)
Targeting IL-23 in human diseases
Mario M. D'Elios et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
The Receptor SIGIRR Suppresses Th17 Cell Proliferation via Inhibition of the Interleukin-1 Receptor Pathway and mTOR Kinase Activation
Muhammet F. Gulen et al.
IMMUNITY (2010)
Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1
Frank L. van de Veerdonk et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Kamran Ghoreschi et al.
NATURE (2010)
The S1P1-mTOR axis directs the reciprocal differentiation of TH1 and Treg cells
Guangwei Liu et al.
NATURE IMMUNOLOGY (2010)
Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells
Monica Montes et al.
CLINICAL IMMUNOLOGY (2009)
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
Erin E. Longbrake et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
Yeonseok Chung et al.
IMMUNITY (2009)
Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes
Anneli Jaeger et al.
JOURNAL OF IMMUNOLOGY (2009)
Cutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells
Amit Awasthi et al.
JOURNAL OF IMMUNOLOGY (2009)
The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR
Guangwei Liu et al.
NATURE IMMUNOLOGY (2009)
Repeated subcutaneous injections of IL12/23 P40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
Benjamin M. Segal et al.
LANCET NEUROLOGY (2008)
TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology
Mandy J. McGeachy et al.
NATURE IMMUNOLOGY (2007)
Interleukin (IL)-23 p19 expression induced by IL-1β in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-κB and AP-1 dependent pathway
F.-L. Liu et al.
RHEUMATOLOGY (2007)
Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17
Salome LeibundGut-Landmann et al.
NATURE IMMUNOLOGY (2007)
Cutting edge: Alternative signalin of Th17 cell development by sphingosine 1-phosphate
Jia-Jun Liao et al.
JOURNAL OF IMMUNOLOGY (2007)
STAT3 regulates cytokine-mediated generation of inflammatory helper T cells
Xuexian O. Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia
Yonghai Li et al.
BRAIN (2007)
Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function
Marco Idzko et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Spencer C. Liang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis
Caroline Sutton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice
Mi-La Cho et al.
JOURNAL OF IMMUNOLOGY (2006)
The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells
H Müller et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4
WT Watford et al.
IMMUNOLOGICAL REVIEWS (2004)
Divergent pro- and Antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation
CA Murphy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2
SW Paugh et al.
FEBS LETTERS (2003)
A unique role for IL-23 in promoting cellular immunity
CSR Lankford et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p4O monoclonal antibody
HPM Brok et al.
JOURNAL OF IMMUNOLOGY (2002)
A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R
C Parham et al.
JOURNAL OF IMMUNOLOGY (2002)
Sphingosine 1-phosphate induces chemotaxis of immature dendritic cells and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses
M Idzko et al.
FASEB JOURNAL (2002)
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12
B Oppmann et al.
IMMUNITY (2000)
Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa
F Luzza et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
